Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Pathology, Kyoto City Hospital, Kyoto, Japan.
Ann Surg Oncol. 2022 May;29(5):2944-2956. doi: 10.1245/s10434-021-11132-5. Epub 2021 Dec 2.
BACKGROUND: Transient receptor potential vanilloid 2 (TRPV2) is a highly Ca-permeable ion channel that is involved in a number of cellular processes. It is expressed in various human cancers; however, the role of TRPV2 in gastric cancer (GC) remains poorly understood. METHODS: TRPV2 gene expression was knocked down in GC cell lines by small-interfering RNA (siRNA), and the biological roles of TRPV2 in the proliferation, migration, and invasion of GC cells were then investigated. The gene expression profile of GC was elucidated using a microarray analysis. TRPV2 expression in tumor tissue sections was analyzed by immunohistochemistry. RESULTS: The migration and invasion abilities of GC cells were inhibited by the knockdown of TRPV2. Moreover, the microarray assay revealed that TRPV2 was associated with the transforming growth factor (TGF)-β signaling pathway. Immunohistochemical staining showed that the strong expression of TRPV2 correlated with lymphatic invasion, venous invasion, pathological T (pT), pathological N (pN), and a poor prognosis in GC patients. CONCLUSIONS: TRPV2 appeared to promote tumor migration and invasion via the TGF-β signaling pathway, and the strong expression of TRPV2 was associated with a worse prognosis in GC patients.
背景:瞬时受体电位香草素 2(TRPV2)是一种高钙通透性离子通道,参与多种细胞过程。它在各种人类癌症中表达,但 TRPV2 在胃癌(GC)中的作用仍知之甚少。
方法:通过小干扰 RNA(siRNA)敲低 GC 细胞系中的 TRPV2 基因表达,然后研究 TRPV2 在 GC 细胞增殖、迁移和侵袭中的生物学作用。使用微阵列分析阐明 GC 的基因表达谱。通过免疫组织化学分析肿瘤组织切片中 TRPV2 的表达。
结果:TRPV2 的敲低抑制了 GC 细胞的迁移和侵袭能力。此外,微阵列检测表明 TRPV2 与转化生长因子(TGF)-β信号通路有关。免疫组织化学染色显示,TRPV2 的强表达与 GC 患者的淋巴侵袭、静脉侵袭、病理 T(pT)、病理 N(pN)和预后不良相关。
结论:TRPV2 似乎通过 TGF-β 信号通路促进肿瘤迁移和侵袭,TRPV2 的强表达与 GC 患者的预后不良相关。
J Exp Clin Cancer Res. 2020-10-2
Sci Rep. 2019-11-5
J Cell Mol Med. 2016-6
World J Gastroenterol. 2012-12-7
Sci Rep. 2025-9-1
Ann Surg Oncol. 2025-8-29
Ann Surg Oncol. 2025-8-19
Cancer Cell Int. 2024-9-27
J Gastroenterol. 2024-7
Cancers (Basel). 2023-12-21
World J Clin Oncol. 2023-10-24
Mol Hum Reprod. 2023-8-30
J Cell Sci. 2016-5-1